|
| |
| | | 62860 | | 23.06.2014 | | AbbVie AG | | | | | | | 22.06.2024 | | | | | | 07.15. | | 04.12.2021 | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Humira | Injektionslösung in Durchstechflasche | Injection solution (Adalimumab 40mg / 0.8ml) + Injection solution () | L04AB04 | CI | | 02 | Humira | | (Adalimumab 40 mg) | | |
|
|
|
